Table 3.

Response to second line chemotherapy in patients with mucinous ovarian cancer with a recurrence free interval > 6 months compared to other histological subtypes

	Mucinous	Other histotypes	p
N pts.	20	388
Type of second line chemotherapy	19	384
Platinum single agent	(8) 42.1%	(67) 17.4%	0.0259*
Platinum based combination	(6) 31.6%	(184) 47.9%
No platinum	(5) 26.3%	(133) 34.6%
Response rate to second line
All evaluable patients	11	340
CR + PR	(4) 36.4%	(213) 62.6%	0.0407*
Platinum	7	227
CR + PR	(4) 57.1%	(170) 74.9%	n.s.*
Non-platinum	4	113
CR + PR	(-) 0%	(43) 38.1%	n.s.*
Number of chemotherapy lines received for recurrence
Mean (± s.d.)	1.9 ± 1.1	2.8 + 1.3	0.0023**

* χ²; **t-test